Challenges in the Use of Anthrax Vaccine Adsorbed

The Board explored challenges regarding Anthrax Vaccine Absorbed (AVA) and considered options for pre- and post-event research. AVA is not licensed for use in children and there is no clinical data on its use in pediatric populations for pre- or post-exposure prophylaxis in children. The Board recommended that HHS plan and conduct a pre-event research study.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Enter your email address to receive important announcements and updates through the ASPR TRACIE Listserv.